SCHEMBL5327504

SCHEMBL5327504

COc1cc(CCO)ccc1OCCCN1CCC(c2onc3cc(F)ccc23)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.58
DRD2 P14416 4/20 0.58
HTR2A P28223 4/20 0.58
HRH3 Q9Y5N1 3/20 0.58
ABCB11 O95342 1/20 0.54
CHRM2 P08172 1/20 0.54
ADRA2A P08913 1/20 0.54
CHRM1 P11229 1/20 0.54
ADRA2B P18089 1/20 0.54
ADRA2C P18825 1/20 0.54
DRD1 P21728 1/20 0.54
DRD4 P21917 1/20 0.54
ACHE P22303 1/20 0.54
SLC6A2 P23975 1/20 0.54
HTR2C P28335 1/20 0.54
SLC6A4 P31645 1/20 0.54
CCKBR P32239 1/20 0.54
ADRA1A P35348 1/20 0.54
HRH1 P35367 1/20 0.54
OPRM1 P35372 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8788670 0.90 HTR1A (0.60) HTR1ADRD2HTR2AHRH3ABCB11
Hydrochloric Acid SCHEMBL8788063 0.90 HTR1A (0.56) HTR1ADRD2HTR2AHRH3ABCB11
SCHEMBL8787386 0.89 HTR1A (0.59) HTR1ADRD2HTR2AHRH3ABCB11
SCHEMBL3121106 0.89 HTR1A (0.58) HTR1ADRD2HTR2AHRH3ABCB11
SCHEMBL8787589 0.88 HTR1A (0.56) HTR1ADRD2HTR2AHRH3ABCB11
SCHEMBL8786547 0.86 HTR1A (0.56) HTR1ADRD2HTR2AHRH3ABCB11
Fumaric Acid SCHEMBL8787274 0.86 HTR1A (0.53) HTR1ADRD2HTR2AHRH3ABCB11
SCHEMBL8788937 0.85 HTR1A (0.53) HTR1ADRD2HTR2AHRH3ABCB11
SCHEMBL3646700 0.85 ABCB11 (0.63) HTR1ADRD2HTR2AABCB11CHRM2
SCHEMBL8786969 0.85 HTR1A (0.54) HTR1ADRD2HTR2AHRH3ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2825167-A1 AN ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS Vanda Pharmaceuticals Inc. (US) 2015-01-21 EP disclosed
WO-2013138602-A1 AN ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS VANDA PHARMACEUTICALS INC. (US) 2013-09-19 WO disclosed
WO-2007137224-A2 METHOD OF TREATMENT VANDA PHARMACEUTICALS, INC. (US) 2007-11-29 WO disclosed